Zobrazeno 1 - 10
of 191
pro vyhledávání: '"Ammar A, Javed"'
Publikováno v:
Cancers, Vol 16, Iss 3, p 489 (2024)
Pancreatic ductal adenocarcinoma (PDAC) remains associated with poor outcomes with a 5-year survival of 12% across all stages of the disease. These poor outcomes are driven by a delay in diagnosis and an early propensity for systemic dissemination of
Externí odkaz:
https://doaj.org/article/b4ae280b68be46ffa1b9ac7bcd297510
Autor:
Louisa Bolm, MD, Martina Nebbia, MD, Alice C. Wei, MD, Amer H. Zureikat, MD, Carlos Fernández-del Castillo, MD, Jian Zheng, MD, Alessandra Pulvirenti, MD, Ammar A. Javed, MD, Yurie Sekigami, MD, Natalie Petruch, Motaz Qadan, MD, PhD, Keith D. Lillemoe, MD, Jin He, MD, Cristina R. Ferrone, MD, the Pancreatic Neuroendocrine Disease Alliance (PANDA)
Publikováno v:
Annals of Surgery Open, Vol 4, Iss 2, p e277 (2023)
Externí odkaz:
https://doaj.org/article/8e6751d51c704aae9a48f609c79ae263
Autor:
Louisa Bolm, MD, Martina Nebbia, MD, Alice C. Wei, MD, Amer H. Zureikat, MD, Carlos Fernández-del Castillo, MD, Jian Zheng, MD, Alessandra Pulvirenti, MD, Ammar A. Javed, MD, Yurie Sekigami, MD, Natalie Petruch, MD, Motaz Qadan, MD, PhD, Keith D. Lillemoe, MD, Jin He, MD, Cristina R. Ferrone, MD, the PAncreatic Neuroendocrine Disease Alliance (PANDA)
Publikováno v:
Annals of Surgery Open, Vol 4, Iss 1, p e245 (2023)
Externí odkaz:
https://doaj.org/article/9a8b37a9595145f3be2cd1fe113068f9
Autor:
Louisa, Bolm, Martina, Nebbia, Alice C, Wei, Amer H, Zureikat, Carlos, Fernández-Del Castillo, Jian, Zheng, Alessandra, Pulvirenti, Ammar A, Javed, Yurie, Sekigami, Natalie, Petruch, Motaz, Qadan, Keith D, Lillemoe, Jin, He, Cristina R, Ferrone
Publikováno v:
Annals of surgery. 276(3)
The role of parenchyma-sparing resections (PSR) and lymph node dissection in small (3 cm) nonfunctional pancreatic neuroendocrine tumors (PNET) is unlikely to be studied in a prospective randomized clinical trial. By combining data from 4 high-volume
Autor:
Ammar A. Javed, MD, Alina Hasanain, MD, Aleezay Haider, George Jones, BS, Zunaira N. Javed, Kevin Soares, MD, Richard A. Burkhart, MD, John L. Cameron, MD, FACS, Matthew J. Weiss, MD, FACS, Christopher L. Wolfgang, MD, PhD, FACS, Jin He, MD, PhD, FACS
Publikováno v:
Journal of Pancreatology, Vol 2, Iss 2, Pp 29-34 (2019)
Abstract. Background:. Functional pancreatic neuroendocrine tumors (f-PanNETs) are rare tumors of the pancreas that are associated with excess hormone production. A majority of literature available on these tumors is limited to case reports and small
Externí odkaz:
https://doaj.org/article/3daea39a47fb4147ab6e8e99ed1693de
Autor:
Ammar A, Javed, Alessandra, Pulvirenti, Samrah, Razi, Jian, Zheng, Theodoros, Michelakos, Yurie, Sekigami, Elizabeth, Thompson, David S, Klimstra, Vikram, Deshpande, Aatur D, Singhi, Matthew J, Weiss, Christopher L, Wolfgang, John L, Cameron, Alice C, Wei, Amer H, Zureikat, Cristina R, Ferrone, Jin, He
Publikováno v:
Annals of surgery.
To identify factors associated with concordance between World Health Organization (WHO) grade on cytological analysis (c-grade) and histopathological analysis (h-grade) of surgical specimen in patients with PanNETs and examine trends in utilization a
Autor:
Sami Shoucair, Jianan Chen, James R. Martinson, Joseph R. Habib, Benedict Kinny-Köster, Ning Pu, A. Floortje van Oosten, Ammar A. Javed, Eun Ji Shin, Syed Z. Ali, Kelly J. Lafaro, Christopher L. Wolfgang, Jin He, Jun Yu
Publikováno v:
JAMA Surg
IMPORTANCE: The use of neoadjuvant therapy (NAT) in resectable pancreatic ductal adenocarcinoma (PDAC) remains controversial. A favorable pathologic response (complete or marked tumor regression) to NAT is associated with better outcomes in patients
Autor:
Elie M. Ghabi, Sami Shoucair, Ding Ding, Ammar A. Javed, Elizabeth D. Thompson, Lei Zheng, John L. Cameron, Christopher L. Wolfgang, Christopher R. Shubert, Kelly J. Lafaro, Richard A. Burkhart, William R. Burns, Jin He
Publikováno v:
J Gastrointest Surg
BACKGROUND: The role of postoperative chemotherapy in patients with resected pancreatic cancer who receive neoadjuvant treatment is unknown. Clinicians use changes in CA19-9 and histopathologic scores to assess treatment response. We sought to invest
Autor:
Ammar A. Javed, Ding Ding, Alina Hasanain, Floortje van Oosten, Jun Yu, John L. Cameron, Richard A. Burkhart, Lei Zheng, Jin He, Christopher L. Wolfgang
Publikováno v:
Annals of Surgery. 277:859-865
Autor:
Ammar A, Javed, A, Floortje van Oosten, Joseph R, Habib, Alina, Hasanain, Benedict, Kinny-Köster, Georgios, Gemenetzis, Vincent, Groot, Ding, Ding, John L, Cameron, Kelly J, Lafaro, William R, Burns, Richard A, Burkhart, Jun, Yu, Jin, He, Christopher L, Wolfgang
Publikováno v:
Annals of Surgery. 277:866-872
The aim of the study was to assess the association of circulating tumor cells (CTCs) with survival as a biomarker in pancreatic ductal adenocarcinoma (PDAC) within the context of a delay in initiation of adjuvant therapy.Outcomes in patients with PDA